PL369504A1 - Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease - Google Patents

Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease

Info

Publication number
PL369504A1
PL369504A1 PL01369504A PL36950401A PL369504A1 PL 369504 A1 PL369504 A1 PL 369504A1 PL 01369504 A PL01369504 A PL 01369504A PL 36950401 A PL36950401 A PL 36950401A PL 369504 A1 PL369504 A1 PL 369504A1
Authority
PL
Poland
Prior art keywords
crohn
disease
preparation
treatment
pharmaceutical composition
Prior art date
Application number
PL01369504A
Other languages
Polish (pl)
Other versions
PL203297B1 (en
Inventor
Klüver Jepsen Svenn
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Priority to PL369504A priority Critical patent/PL203297B1/en
Publication of PL369504A1 publication Critical patent/PL369504A1/en
Publication of PL203297B1 publication Critical patent/PL203297B1/en

Links

PL369504A 2001-10-15 2001-10-15 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease PL203297B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL369504A PL203297B1 (en) 2001-10-15 2001-10-15 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL369504A PL203297B1 (en) 2001-10-15 2001-10-15 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease

Publications (2)

Publication Number Publication Date
PL369504A1 true PL369504A1 (en) 2005-04-18
PL203297B1 PL203297B1 (en) 2009-09-30

Family

ID=35070238

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369504A PL203297B1 (en) 2001-10-15 2001-10-15 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease

Country Status (1)

Country Link
PL (1) PL203297B1 (en)

Also Published As

Publication number Publication date
PL203297B1 (en) 2009-09-30

Similar Documents

Publication Publication Date Title
IL245955B (en) Immunogenic compositions for the prevention and treatment of meningococcal disease
IL199437A (en) Use of at least one bacteria strain in the preparation of a dietary and/or pharmaceutical composition for the prevention or treatment of hyperoxaluria
HUP1500560A2 (en) Thioflavin derivatives and their use in diagnosis and treatment of alzheimer's disease
HUP0303037A3 (en) Compounds to treat alzheimer's disease and pharmaceutical compositions containing them
HUP0202338A3 (en) Pharmaceutical composition containing fenofibrate and preparation method
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
HUP0400607A3 (en) Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
IL149924A0 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
HK1068282A1 (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for usein treatment of ulcerative colitis and crohn's di sease
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
PL344246A1 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
EG24584A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of uicerative colitis and crohn's disease
EP1404281A4 (en) Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries
HUP0401325A3 (en) Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds
HUP0303977A3 (en) Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical nad alimentary fields
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
GB9912639D0 (en) Improvements in and relating to treatment of respiratory conditions
HUP0102987A3 (en) Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
PL369504A1 (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease
EP1322778A4 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
EP1189584A4 (en) Alpha amino acid composition and method for the treatment of skin
EP1535620A4 (en) The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention
PL357466A1 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them